Volume 26, Issue 12 pp. 2850-2858
Article
Full Access

High-level expression of the ER-MP58 antigen on mouse bone marrow hematopoietic progenitor cells marks commitment to the myeloid lineage

Marella F. T. R. De Bruijn

Corresponding Author

Marella F. T. R. De Bruijn

Department of Immunology, Erasmus University, Rotterdam, The Netherlands

Department of Immunology, Erasmus University, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands, Fax: 31-10-436-7601Search for more papers by this author
Rob E. Ploemacher

Rob E. Ploemacher

Department of Hematology, Erasmus University, Rotterdam, The Netherlands

Search for more papers by this author
Angelique E. M. Mayen

Angelique E. M. Mayen

Department of Hematology, Erasmus University, Rotterdam, The Netherlands

Search for more papers by this author
Jane S. A. Voerman

Jane S. A. Voerman

Department of Immunology, Erasmus University, Rotterdam, The Netherlands

Search for more papers by this author
Walentina A. T. Slieker

Walentina A. T. Slieker

Department of Immunology, Erasmus University, Rotterdam, The Netherlands

Search for more papers by this author
Willem van Ewijk

Willem van Ewijk

Department of Immunology, Erasmus University, Rotterdam, The Netherlands

Search for more papers by this author
Pieter J. M. Leenen

Pieter J. M. Leenen

Department of Immunology, Erasmus University, Rotterdam, The Netherlands

Search for more papers by this author
First published: December 1996
Citations: 25

Abstract

Studies on the early events in the differentiation of the nonspecific immune system require the identification and isolation of myeloid-committed progenitor cells. Using the monoclonal antibodies (mAb) ER-MP12 and ER-MP20, generated against immortalized macrophage precursors, we have shown previously that the earliest macrophage colony-stimulating factor (M-CSF)-responsive cells in the bone marrow have the ER-MP12hi20 phenotype. In addition, we found that the ER-MP12hi20 subset (comprising about 2 % of total nucleated marrow) contains progenitor cells of all hematopoietic lineages. Aiming at the identification and purification of the myeloid progenitor cells within the ER-MP12hi20 subset, we used ER-MP58, a marker expressed at high level by all M-CSF-responsive bone marrow progenitors. With this marker the ER-MP12hi20 cell population could be divided into three subfractions: one with absent or low level ER-MP58 expression, one with intermediate, and one with high ER-MP58 expression. These subfractions were isolated by fluorescence-activated cell sorting and tested in vitro and in vivo for their differentiation capacities. In addition, the expression of ER-MP58 on stem cell subsets was examined in the cobblestone area-forming cell (CAFC) assay. Our data indicate that in the ER-MP12hi20 subpopulation myeloid-committed progenitors are characterized by high-level expression of the ER-MP58 antigen, whereas cells with other or broader differentiation capacities have an ER-MP58 negative/low or intermediate phenotype. These myeloid-committed progenitors have no significant repopulating ability in vivo, in contrast to the ER-MP58 intermediate cells. Primitive CAFC-28/35, corresponding to cells providing long-term hematopoietic engraftment in vivo, also did not express the ER-MP58 Ag at a high level. Thus, cells committed to the myeloid lineage can be separated from progenitor cells with other differentiation capacities by means of multiparameter cell sorting using ER-MP58 in combination with ER-MP12 and ER-MP20.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.